Skip to main content
. 2019 Jul 29;9:10966. doi: 10.1038/s41598-019-47439-3

Figure 3.

Figure 3

Representative results of Sanger sequencing, MSI and immunohistochemical analysis of MLH1 expression of a germline MLH1 V384D mutant case. (a) Sanger sequencing of MLH1 V384D for tumor and matched normal revealed that it is germline heterozygous variant. (b) MSI profiles with five Bethesda markers in the same case demonstrated MSS. (c) Representative cases with focal loss of MLH1 expression in a mutant case and intact MLH1 expression in a wild-type case. Abbreviations: T = tumor tissue; N = normal tissue.